Last reviewed · How we verify
NCT03958006
Simultaneous Cochlear Implantation During Translabyrinthine Resection of Vestibular Schwannoma
NA trial testing Cochlear implant in Vestibular Schwannoma in 6 participants. Completed in 30 January 2023.
30 January 2023
Quick facts
| Lead sponsor | Henry Ford Health System |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 6 |
| Start date | 5 December 2018 |
| Primary completion | 30 January 2023 |
| Estimated completion | 30 January 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Cochlear implant
Conditions studied
- Vestibular Schwannoma — all drugs for Vestibular Schwannoma →
- Cochlear Implantation — all drugs for Cochlear Implantation →
Sponsor
Henry Ford Health System — full company profile →
Who can join
Adults 18 to 99, any sex, with Vestibular Schwannoma or Cochlear Implantation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will address the feasibility of simultaneous cochlear implantation during resection of a vestibular schwannoma.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03958006
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cochlear implant
Trials testing the same drug.
- NCT06860152 — Cochlear Implant Speech in Noise Processing · NA · recruiting
- NCT06085885 — Tinnitus and Cochlear Implants · enrolling by invitation
- NCT03500718 — Changes in the Threshold of Electrically Evoked Compound Action Potential in Children Following Cochlear Implantation · NA · completed
- NCT03134989 — Cochlear Response Telemetry and Hearing Preservation · terminated
- NCT03052920 — Cochlear Implantation in Adults With Asymmetric Hearing Loss Clinical Trial · NA · completed
Other recruiting trials for Vestibular Schwannoma
Currently open trials in the same condition.
- NCT07364955 — Vestibular Rehabilitation Protocol in Unilateral Vestibular Schwannoma · NA · recruiting
- NCT07130851 — Mapping of Vestibular Centers Activation Using fMRI in Patients With Vestibular Schwannoma · NA · active not recruiting
- NCT06572475 — USPIO Enhanced MR Imaging in CNS Tumours (UMIC) · NA · recruiting
- NCT06112509 — Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery · NA · recruiting
- NCT05641441 — Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma · recruiting
Other Henry Ford Health System trials
Trials by the same sponsor.
- NCT07450183 — Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1 · Phase 2 · not yet recruiting
- NCT07418853 — Comparison of Goniotomy Device Outcomes in Combined Phacoemulsification-goniotomy Surgeries · NA · not yet recruiting
- NCT06670287 — The Use of Multiple Sensors to Track Sleep in Nightshift Workers · NA · recruiting
- NCT07363525 — Michigan Initial Experience Using Tigertriever for Thrombectomy · not yet recruiting
- NCT07530172 — Radioembolization Versus External Radiation Therapy · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03958006 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Henry Ford Health System
- Last refreshed: 20 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03958006.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing